Peritoneal Dialysis Market

Global Peritoneal Dialysis Market Share, Size, Growth, Analysis, Forecast: By Treatment Type: Continuous Ambulatory Dialysis Services, Automated Peritoneal Dialysis Services; By Product Type: Peritoneal Dialysis Solutions, Peritoneal Dialysis Devices, Others; By End User; By Treatment Channel; Regional Analysis; Supplier Landscape; 2023-2031

Global Peritoneal Dialysis Market Outlook

The global peritoneal dialysis market size attained a value of nearly USD 4,635.4 million in 2022. The market is likely to grow at a CAGR of 6.4% during the forecast period of 2023-2031 to attain a value of USD 8,105.5 million by 2031.

 

Key Trends in the Market

With peritoneal dialysis (PD), a soft plastic tube or catheter is surgically implanted into the abdominal lining or belly to treat kidney failure. The two types of peritoneal dialysis are continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). These methods enable more flexible treatment options, lessen the need to visit dialysis facilities, and produce better clinical results, which means less drugs and fewer dietary restrictions.

 

  • Peritoneal dialysis has the benefit that it can be performed at home and does not necessitate frequent journeys to a dialysis facility. Patients undergoing peritoneal dialysis also have less food and fluid restrictions than those undergoing haemodialysis. This is anticipated to increase the demand for peritoneal dialysis and, as a result, fuel the peritoneal dialysis market growth in the upcoming years.
  • The rising incidence of diabetes, hypertension, and end-stage renal disease (ESRD), along with the growing need for kidney donors and the growing consumer knowledge of the hazards of kidney transplants, are the primary factors driving the market's expansion.
  • The significant increase in chronic kidney disease (CKD) in recent years can be linked to the increasing prevalence of high blood pressure and diabetes. Over time, CKD is worsening and raising the risk of developing heart disease and stroke. This has increased the peritoneal dialysis demand, which is significantly boosting peritoneal dialysis market development.
  • The market is further expanding due to a shift in health professionals' preferences for PD over haemodialysis, which offers better patient mobility at affordable costs while producing less symptom variations. Along with this, various government spending on research and development (R&D), improving reimbursement practises, and ongoing product diversification are encouraging the market expansion.

 

Global Peritoneal Dialysis Market Analysis

Based on treatment type, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The market on the basis of product can be divided into peritoneal dialysis solution, peritoneal dialysis devices, peritoneal dialysis sets, and peritoneal dialysis catheters, among others. On the basis of end use, the market is divided into home-based dialysis and dialysis centre and hospital-based dialysis. The regional markets for peritoneal dialysis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global peritoneal dialysis market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.  

 

  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG & Co. KGaA 
  • Medtronic plc 
  • Medionics International Inc. 
  • Newsol Technologies Inc. 
  • Others

 

Market Share by Treatment Type

The continuous ambulatory peritoneal dialysis (CAPD) market is anticipated to have significant revenue growth during the forecast period. CAPD is a type of peritoneal dialysis that can be done manually, without a machine, and constantly throughout the day. The method is new for the treatment of end-stage renal disease. The benefits include improved blood pressure management, a discernible improvement in anaemia, and an unrestricted diet, thus aiding the peritoneal dialysis market growth. 

 

Additionally, CAPD provides a greater clearance of medicines with a higher molecular weight than haemodialysis. Both therapies are intended to be performed over a 24-hour period, however CAPD does not employ a cycler and APD does. The cycler is a programmable machine that controls the solution exchange, enabling usage of APDs throughout the night while the patient is asleep. 

 

Market Share by Region

North America is anticipated to hold one of the largest market shares during the forecast period. This is due to the high awareness of the peritoneal dialysis technology, the established healthcare industry, and the rising incidence of end-stage renal disease (ESRD) and chronic kidney disease (CKD). 

 

An increase in CKD patients in North America has been caused by the rising numbers of people with diabetes and high blood pressure. This has caused a sharp increase in the demand for peritoneal dialysis among kidney patients, which is anticipated to propel the peritoneal dialysis market in the region. Additionally, the existence of significant producers like Baxter, and other leading producers has improved access to a variety of dialysis products at competitive prices, which is anticipated to fuel the regional market growth. 

 

peritoneal dialysis market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

Baxter International, Inc., which was established in 1931 and has its headquarters in the United States, offers a variety of medical supplies. Its product and service offerings include sterile intravenous solutions, generic injectable medications, parenteral nutrition therapy, infusion systems and devices, inhaled anaesthetics, surgical haemostat and sealant products, and dialysis for both acute and chronic illnesses.

 

B. Braun Melsungen AG, since its founding in 1839 has developed, produced, and distributed pharmaceutical and medical technology goods as well as offered healthcare services. B. Braun sells equipment and systems for surgery, extracorporeal blood transfusion, intensive care, and anaesthesia. Additionally, it provides services for medical practises, clinics, and the home health care industry. 

 

Fresenius Medical Care AG & Co. KGaA, a global healthcare company with its headquarters in Germany and founded in 1996, provides high-quality goods and services for hospitals, outpatient care, and dialysis, with about 3.8 million patients receiving dialysis on a regular basis globally. 

 

Other market players include Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2016-2022
Forecast Period 2023-2031
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Product Type
  • End User
  • Treatment Channel
  • Region
Breakup by Treatment Type
  • Continuous Ambulatory Dialysis Services
  • Automated Peritoneal Dialysis Services
Breakup by Product Type
  • Peritoneal Dialysis Solutions
  • Peritoneal Dialysis Devices
  • Peritoneal Dialysis Sets
  • Peritoneal Dialysis Catheters
  • Others Peritoneal Dialysis Products
Breakup by End User
  • Home- Based Dialysis
  • Dialysis Centers & Hospitals
  • Others
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • DaVita Inc.
  • Baxter
  • B. Braun Melsungen AG
  • Diaverum
  • Nipro
  • Nxstage Medical, Inc.
  • Nikkiso Co., Ltd.
  • Mar Cor Purification
  • Asahi Kasei Medical Co., Ltd.
  • Rockwell Medical
  • Medtronic
  • Dialifegroup
  • JMS Co.Ltd.
  • Atlantic Biomedical
  • 3M
  • Allmed Medical Care Holdings Limited.
  • Isopure Corp.
  • C. R. Bard, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Peritoneal Dialysis Market Overview 

    3.1    Global Peritoneal Dialysis Market Historical Value (2016-2022) 
    3.2    Global Peritoneal Dialysis Market Forecast Value (2023-2031)
4    Global Peritoneal Dialysis Market Landscape
    4.1    Peritoneal Dialysis: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Peritoneal Dialysis: Product Landscape
        4.2.1    Analysis by Treatment Type
        4.2.2    Analysis by Product Type
        4.2.3    Analysis by End User
5    Global Peritoneal Dialysis Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Peritoneal Dialysis Market Segmentation
    6.1    Global Peritoneal Dialysis Market by Treatment Type
        6.1.1    Market Overview
        6.1.2    Continuous Ambulatory Dialysis Services
        6.1.3    Automated Peritoneal Dialysis Services
    6.2    Global Peritoneal Dialysis Market by Product Type
        6.2.1    Market Overview
        6.2.2    Peritoneal Dialysis Solutions
        6.2.3    Peritoneal Dialysis Devices
        6.2.4    Peritoneal Dialysis Sets
        6.2.5    Peritoneal Dialysis Catheters
        6.2.6    Others Peritoneal Dialysis Products
    6.3    Global Peritoneal Dialysis Market by End User
        6.3.1    Market Overview
        6.3.2    Home- Based Dialysis
        6.3.3    Dialysis Centers & Hospitals
        6.3.4    Others
    6.4    Global Peritoneal Dialysis Market by Treatment Channel
        6.4.1    Market Overview
        6.4.2    Public
        6.4.3    Private
    6.5    Global Peritoneal Dialysis Market by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Peritoneal Dialysis Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Peritoneal Dialysis Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Peritoneal Dialysis Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Peritoneal Dialysis Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Peritoneal Dialysis Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1    Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    DaVita Inc.
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    Baxter
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    B. Braun Melsungen AG
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Diaverum
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Nipro
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Nxstage Medical, Inc.
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Nikkiso Co., Ltd.
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Mar Cor Purification
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Asahi Kasei Medical Co., Ltd.
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Rockwell Medical
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    Medtronic
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    Dialifegroup
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    JMS Co.Ltd.
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    Atlantic Biomedical
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
    18.15    3M
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisitions
        18.15.5    Certifications
    18.16    Allmed Medical Care Holdings Limited.
        18.16.1    Financial Analysis
        18.16.2    Product Portfolio
        18.16.3    Demographic Reach and Achievements
        18.16.4    Mergers and Acquisitions
        18.16.5    Certifications
    18.17     Isopure Corp.
        18.17.1    Financial Analysis
        18.17.2    Product Portfolio
        18.17.3    Demographic Reach and Achievements
        18.17.4    Mergers and Acquisitions
        18.17.5    Certifications
    18.18    C. R. Bard, Inc.
        18.18.1    Financial Analysis
        18.18.2    Product Portfolio
        18.18.3    Demographic Reach and Achievements
        18.18.4    Mergers and Acquisitions
        18.18.5    Certifications
19    Peritoneal Dialysis Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The peritoneal dialysis market was valued at USD 4635.4 million in 2022.

The market is expected to grow at a CAGR of 6.4% from 2023 to 2031 to reach a value of USD 8105.5 million by 2031.

The major drivers of the peritoneal dialysis market include the increasing cases of hypertension, diabetes, and end-stage renal disease (ESRD), the growing prevalence of chronic kidney disease (CKD), and the shifting inclination of health practitioners toward PD over haemodialysis.

The extensive investments in research and development activities by governments, improving reimbursement policies, ongoing product diversification, and well-established healthcare sector are the key industry trends propelling the growth of the market.

The major players in the industry are Baxter International, Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Medionics International Inc., and Newsol Technologies Inc., among others.

The most typical kind of PD is continuous ambulatory peritoneal dialysis. Self-dialysis of this kind is performed every day of the week, with four to five exchanges of fresh solutions per day.

While the functionality of peritoneal dialysis and haemodialysis are similar, peritoneal dialysis is safer as it can be conducted regularly, preventing build-up of fluids. As haemodialysis requires visits to a centre dialysis, risks of missing appointments and build-ups of fluid is higher.

Infection is one of the most dangerous complications of peritoneal dialysis and can appear in the skin around the catheter or inside the abdominal cavity in the form of peritonitis. The development of a hernia, a weakening in the abdominal muscles, is another potential but less severe side effect of peritoneal dialysis.

Purchase Full Report

Mini Report

$ 3499     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 7999     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 9999     $5999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER